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     SUMMARY
Eastern and Southern Africa Centre of International Parasite Control (ESACIPAC) conducted 
stool examinations for soil transmitted helminthiases (STH) and Schistosoma mansoni, among 
school children in Mwea Division, Central Kenya where both infections are endemic. Mass drug 
administrations (MDAs) were then conducted in 2004 and 2005 using schoolteachers trained 
on how to administer treatment, physically and psychologically prepare the children to take 
the medication, have them eat before treatment, handle minor and refer serious side effects to 
local health facilities. Local health workers were on standby to help manage severe side effects. 
This study examined side effects of the drugs and the teachers’ preparedness to handle the 
children when such effects occurred. No serious side effects requiring referral to the health 
centre occurred and the minor ones observed were temporal.
In 2005 children in Mwea schools were treated with albendazole 400mg and praziquantel 
40mg/kg body weight while those of Ndia, a neighboring division treated with only albendazole 
400mg since there was low S.mansoni prevalence. Monitoring of side effects was done in two 
schools of Ndia and in three of Mwea through a questionnaire distributed to grade three pupils 
a week after treatment. 
Of 73 pupils from Mwea, 49.7% reported incidences of stomachache, vomiting/nausea, headache 
and dizziness whereas 39.2% of 186 from Ndia experienced incidences of cough, stomachache 
and headache. This shows that more pupils from Mwea, (albendazole and praziquantel) than 
from Ndia (albendazole alone) experienced minor side effects.   
These results show that both drugs have temporary, minor side effects, which can be managed 
by trained schoolteachers by ensuring that the school children do not swallow the drugs on 
an empty stomach and rest immediately after swallowing the drugs but should be closely 
monitored by health personnel. In this study, one trained schoolteacher could administer 
treatment to three hundred children in one day, which makes the approach cost effective and 
should be adopted nationally. 
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Introduction
Soil-transmitted helminthiasis (STHs) and 
schistosomiasis infections are big burdens to school 
age children in large parts of the world [1] including 
Kenya [2]. They can interfere with the nutritional 
status [3] and the cognitive abilities of children 
[4]. Recently education sectors have been used for 
delivering medicines for parasite control because the 
school network is usually well established than the 
health system in developing countries [5].
A wide scale stool examination for intestinal parasites 
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was conducted followed by MDAs for de-worming 
of STHs and human schistosomes by trained school 
teachers in Mwea division, Central Kenya in March 
2004. In the year 2005, the de-worming activity was 
expanded to the neighboring division, Ndia, which 
has low prevalence of schistosomiasis, less than 
1%, (unpublished data). Albendazole (ALB) and 
praziquantel (PZQ) have been widely used for STH 
and schistosomiasis control [1]. However, though they 
are reported to be safe [6], it is important to monitor 
the events of side effects in the projects when widely 
used for MDA, as there are some reports of severe 
adverse effects (SAEs) of PZQ [2, 7, 8, 9]. In order to 
observe the kinds, the frequency, and the degree of the 
SAEs of these two medicines, a survey was conducted 
one week after the MDA using a questionnaire. 
Materials and Methods
School setting
All primary schools in both Mwea and Ndia division 
were targeted for the de-worming programme. Mwea 
division, which has an irrigation scheme within it, had 
a prevalence of Schistosoma mansoni (Sm), Ascaris 
lumbricoides (Al), hookworm (Hw), and Trichuris 
trichuria (Tt) at 17.4%, 0.0%, 1.4%, and 2.9%, 
respectively following the results of sample schools. 
Ndia division, which does not have an irrigation 
scheme, had a prevalence of Sm, Al, Hw, and Tt 
was 0.6%, 1.3%, 20.9%, and 1.8%, respectively. 
[unpublished data] and treatment was done for STH 
only.
De-worming 
Schoolteachers who were trained by staff from the 
district education office, the district medical office, 
and ESACIPAC administered tablets. The training 
session which lasted half a day introduced the 
teachers to the aims of the school health programme, 
the presence of worms in the area, characteristics 
of the de-worming drugs, their safety and storage, 
administration of the de-worming drugs, the need to 
physically and psychologically prepare each child to 
take the drugs and record keeping. The training also 
had a practical session on drug administration, during 
which the teachers practically administered the drugs 
to a selected number of pupils who would then not be 
treated on the scheduled de-worming day. Teachers 
were also asked to ensure that the school children did 
not take the drugs on an empty stomach by having  
them take some food before taking the drugs and also 
have some porridge to swallow the tablets with. Pupils 
of  Ndia took 400mg of ALB tablet (name of the tablets, 
unibazole) and those in Mwea took 400mg of ALB 
and 40mg/kg of PZQ (name of the tablets, prazitel®), 
the dosage of which was adjusted by measuring height 
(WHO, 2002a). Two schools from Ndia (ALB) and 
three schools from Mwea (ALB + PZQ) were targeted 
for monitoring the adverse effects. It was the first time 
for the pupils in Ndia, but the second time for those in 
Mwea to take the tablets during MDA.
Questionnaire
A questionnaire sheet was distributed to the standard 
three pupils who were randomly selected one week 
after the administration of the medication. Under the 
guidance of the teachers, pupils were expected to fill 
the answers by themselves. Questions included: age, 
sex, and whether they had had headache, fever, cough, 
dizziness, diarrhea, stomachache, or vomiting/nausea 
immediately after taking the medication up to the 
following two days.
Statistical analysis
Continuous data between two groups were compared 
by t-test. Categorical data were compared between two 
groups using chi-square test with Yate’s correction. The 
threshold for significant level was 0.05 of p value.
Results
73 pupils in Mwea and 186 pupils in Ndia responded to 
the questionnaire. There was no significant difference 
between the two groups in age and sex. There were 
about fifty per cent (49.7%) incidences of adverse 
effects reported by pupils of Mwea and 39.2 % by 
pupils of Ndia. Among the pupils in the ALB group, 
the most frequent adverse effect was stomachache 
(13.4%), followed by headache (5.5%). Coughing 
which is not a side effect of taking the drugs and could 
have been due to any other cause was reported by 
(16.1%) of the pupils from Ndia. The most frequent 
adverse effect among the pupils in the other group was 
stomachache (30.1%), followed by vomiting/nausea 
(8.2%), headache (5.5%), and dizziness (5.5%).
Twenty-two (30.1%) from Mwea, and 25 
(13.4%) from Ndia (p=0.002) reported incidences of 
stomachache when comparisons were made between 
the side effects of the two regimes. Six (8.2%) pupils 
from Mwea, and 3 (1.6%) from Ndia (p=0.017) 
reported incidences
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Table 1 Adverse effects of treatment with ALB+PZQ and ALB among pupils in Mwea and Ndia Divisions, respectively
              Percentage of respondents %
   Variables     Mwea   Ndia          p-value
             ALB +PZQ (n=73)  ALB alone (n=186)
 Sex: no boys/no girls       39/34   97/90   0.89
 Mean age (SD, range)   11.4 (10.5, 7-15)  10.2 (2.0, 7-17)  0.13 
 Side/adverse effects:   Number (%)  Number (%) 
 Nothing     44(60.3)   113(60.8)  1.00 
 Headache    4(5.5)   5(5.5)   0.28 
 Fever     0(0.0)   6(3.2)   0.19 
 Cough     0(0.0)   30(16.1)   0.00 
 Dizziness    4(5.5)   6(3.2)   0.48 
 Diarrhea     2(2.7)   6(3.2)   1.00 
 Stomachache    22(30.1)   25(13.4)   0.00 
 Vomiting/nausea    6(8.2)   3(1.6)   0.02 
vomiting/nausea. All adverse effects were temporally 
and no severe ones were reported. 
Discussion
The result of this study shows the frequencies of 
the adverse effects of the two drugs used in MDA 
among school children in an area of central Kenya. 
In Ndia Division,where only ALB was used cough 
was reported more frequently than in Mwea Division. 
Cough is a general reaction and can be associated 
with any drug especially in young children. Minor 
gastro-intestinal symptoms were however reported 
after administration of PZQ in Mwea but there were 
no major side effects associated with it. These two 
medicines are widely used in MDA for the control of 
STH and human schistosomes. ALB provides safe and 
highly effective therapy against infections with Al, Tt, 
and Hw administered in a single 400-mg oral dose for 
adults and children more than 2 years of age [10]. It 
has only limited solubility in water. After a 400-mg 
oral dose, ALB cannot be detected in plasma, due to 
low absorbance of the drug from the intestines [10]. 
The metabolites are excreted mainly in the urine. 
ALB is said to produce few side effects when used 
for short-term therapy of STHs. Transient abdominal 
pain, diarrhea, nausea, dizziness, and headache occur 
occasionally [6].
PZQ is used in MDA for schistosomiasis and 
is readily absorbed after oral administration, so that 
maximal levels in human plasma occur in 1 to 2 hours. 
Its plasma half-life is 0.8 to 2.0 hours, but this may be 
prolonged in patients with severe liver disease,  
including those with hepatosplenic schistosomiasis. 
About 70% of an oral dose of PZQ is recovered as 
metabolites in the urine within 24 hours. Abdominal 
discomfort, particularly pain and nausea, headache, 
dizziness, and drowsiness may occur shortly after 
taking PZQ; these direct effects are transient and dose-
related. There is no pharmacokinetic interaction and 
no synergistic effect by the treatment between the two 
medicines [11,12].
After introduction of these two medicines in MDA, 
their side effects have been studied. When Olds [14] 
studied the side effects of ALB and PZQ among the 
children with S.mansoni in Western Kenya, abdominal 
pain, diarrhea, and bloody diarrhea were detected to 
have higher frequency among children who took 
PZQ with or without ALB. On the contrary, this study 
showed only few cases of diarrhea (2.7%), stomachache 
(30.1%) among the children with PZQ and ALB 
probably because emphasis was made on the need to 
take food before taking the medication. Jaoko [2] in 
a study in Southeastern Kenya reported that the main 
side effects were abdominal pain (36.3%), headache 
(35.3%), nausea (13.1%), dizziness (9.7%), and fever 
(7.8%). Berhe [7] also reported that abdominal cramp 
(86.9%), diarrhea with blood and/or mucus (49.5%), 
dizziness (31.2%), and vomiting (24.9%) were the 
most common treatment related symptoms in their 
study in Ethiopia. 
The spectrums of the side effect are not always 
same between different ethnic groups, and it can be in-
fluenced by the genetic factors and even the temporary 
conditions of children at the de-worming activity. To 
the best of our knowledge, it was the first time for the 
pupils in Ndia to join a de-worming activity and it 
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maybe that some may have had difficulties swallow 
the tablets while others may have been scared to do 
so. They might not have had enough information of 
the needs of de-worming and adverse effects, which 
might have led to the high percentage of cough and 
stomachache in this group. On the other hand, it was 
the second round of de-worming activity for the pupils 
in Mwea, and they could take medicine more easily 
as they realized the reason and efficacy of the de-
worming and adverse effects through the activity in 
the previous year and teachers of Mwea schools may 
have appreciated the need to administer the tablets to 
children when they had taken a meal. Stomachache 
and vomiting/nausea were seen more in Mwea, which 
means that these effects were really caused by PZQ 
alone.
Although there were no cases of severe adverse/
side effects, the district medical staff was stand-
by at their workstations on the de-worming day in 
readiness for any emergency cases. Tablets have been 
administered by trained teachers in many projects and 
incase of severe side effects their efficacy may not 
be very good. It is important to monitor the adverse/
side effects, the type and the frequency and use the 
information gathered while training the schoolteachers 
and health staff in the communities, so that they can 
use such information to handle emergency cases.
Conclusions
This study shows that both ALB and PZQ have minor 
side effects, trained schoolteachers can however use the 
two drugs in MDA for control of S. mansoni and STHs 
since schools provide an efficient and effective channel 
to reach large portions of the population within a short 
time, which makes a programme cost effective. The 
school children experienced minor side effects, which 
were temporal and required resting under a shade until 
they subsided. However, the health/medical personnel 
should be involved in the programme so that they can 
give moral support and be on standby to handle any 
severe side effects should they arise. This approach is 
cost effective and should be adopted for a national de-
worming programme.
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